Winder, T; Giamas, G; Wilson, P M; Zhang, W; Bohanes, P; Ning, Y; Gerger, A; Stebbing, J; Lenz, H-J (2014). Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients Q1 treated with tamoxifen. Pharmacogenomics Journal, 14:28-34.
Pohl, A; El-Khoueiry, A; Yang, D; Zhang, W; Lurje, G; Ning, Y; Winder, T; Hu-Lieskoven, S; Iqbal, S; Danenberg, K D; Kahn, M; Teo, J L; Shriki, J; Stebbing, J; Lenz, H J (2013). Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy. Pharmacogenomics Journal, 13(2):173-180.